Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30078583HIVENSG00000113749.8protein_codingHRH2NoNo3274A0A1B0GTK7
P25021
TVIS20009148HPVENSG00000113749.8protein_codingHRH2NoNo3274A0A1B0GTK7
P25021
TVIS20009386HPVENSG00000113749.8protein_codingHRH2NoNo3274A0A1B0GTK7
P25021
TVIS20059821HPVENSG00000113749.8protein_codingHRH2NoNo3274A0A1B0GTK7
P25021
TVIS44038999HTLV-1ENSG00000113749.8protein_codingHRH2NoNo3274A0A1B0GTK7
P25021
TCGA Plot Options
Drug Information
GeneHRH2
DrugBank IDDB00768
Drug NameOlopatadine
Target IDBE0000112
UniProt IDP25021
Regulation Typeantagonist
PubMed IDs16197656
CitationsRosenwasser LJ, O'Brien T, Weyne J: Mast cell stabilization and anti-histamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research. Curr Med Res Opin. 2005 Sep;21(9):1377-87. doi: 10.1185/030079905X56547.
GroupsApproved
Direct ClassificationDibenzoxepines
SMILESCN(C)CCC=C1C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2
PathwaysOlopatadine H1-Antihistamine Action
PharmGKBPA450698
ChEMBLCHEMBL1189432